Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.

Case Studies

Differentiated track record of creating strategic value and delivering growth enabling successful, established healthcare companies to maximise their potential

Jump to:
Caprion Biosciences

Caprion Biosciences

2019 exit: Global leader in cancer immunotherapy laboratory services

Investment
July 2016
Subsector
BioPharma, MedTech
View case study
Quotient Sciences

Quotient Sciences

2019 exit: Globally differentiated pharmaceutical drug development service provider

Investment
December 2015
Subsector
BioPharma
View case study
DDC

DDC

2021 exit: Leading multichannel global diagnostics & testing company

Investment
October 2015
Subsector
BioPharma, Life Science Tools & Diagnostics, MedTech
View case study
BioAgilytix

BioAgilytix

2021 exit: Global industry leader in analytical testing for biologic drug development

Investment
February 2019
Subsector
BioPharma, MedTech
View case study